| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $139.1M | — | +21.5% |
| Gross Profit | $101.2M | — | +27.2% |
| R&D Expense | $27.1M | — | +52.9% |
| SG&A Expense | $23.7M | — | -30.0% |
| Operating Income | $22.6M | — | +679.8% |
| Pre-tax Income | $30.0M | — | +303.5% |
| Income Tax | $1.3M | — | +232.5% |
| Net Income | $28.7M | — | +307.4% |
| EPS (Basic) | $0.36 | — | +300.0% |
| EPS (Diluted) | $0.35 | — | +288.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $263.1M | -27.4% | +41.4% |
| Short-term Investments | $50.3M | +0.0% | — |
| Accounts Receivable | $50.1M | +12.2% | -6.8% |
| Current Assets | $522.2M | +6.9% | +36.3% |
| Total Assets | $1.44B | +2.2% | +9.2% |
| Current Liabilities | $56.1M | -6.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $35.2M | — | +556.8% |
| Capital Expenditures | $3.0M | — | +62.8% |
| Investing Cash Flow | -$128.0M | — | -146.9% |
| Financing Cash Flow | -$6.6M | — | -2.2% |
| Free Cash Flow | $32.3M | — | +810.3% |
| -25.3% |
| Total Liabilities | $92.0M | -4.6% | -23.6% |
| Stockholders' Equity | $1.34B | +2.7% | +12.5% |